Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone

Haemophilia. 2014 Mar;20(2):e185-8. doi: 10.1111/hae.12372.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Anemia, Sickle Cell / complications*
  • Anemia, Sickle Cell / therapy
  • Animals
  • Antibodies / blood
  • Antibodies / immunology
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Factor VIII / administration & dosage
  • Factor VIII / immunology
  • Factor VIII / therapeutic use
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hemophilia A / drug therapy
  • Hemophilia A / etiology*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Male
  • Prednisone / therapeutic use
  • Rituximab

Substances

  • Antibodies
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin G
  • Rituximab
  • Factor VIII
  • Prednisone